HIMS Hims & Hers Health

XNYS Down Alert

· How we analyze

About the company

Hims & Hers is a US telehealth platform. Customers consult doctors online and receive medications and care products by mail, for example for hair loss, erectile dysfunction, skin problems and weight loss. The business runs mostly on subscriptions. As of Oct 12, 2026

Fact sheet (from the annual report) Doctors’ offices and clinics · San Francisco, USA

According to the company, Hims & Hers runs a digital health platform that connects patients with licensed medical professionals via telehealth. Conditions treated include sexual health, hair loss, hormones, weight loss, skin conditions and mental health. Prescribed medications are shipped by its own pharmacies and contracted partner pharmacies. In addition, there are over-the-counter products, partly also through retail partners and stores, as well as lab tests for numerous biomarkers. Many offerings run by subscription and are billed on a recurring basis at the chosen delivery frequency.

Automatically summarized from SEC annual report (10-K, filed Feb 23, 2026) (website of the US Securities and Exchange Commission) · reviewed Oct 14, 2026

Price performance at a glance

Last 30 trading days
  • Today +1.2%
  • 7 days −4.4%
  • 30 days −5.1%
  • 1 year −42.1%
Day range (last trading day)
−1.2%Price at 38% of the range+2.0%
52-week range
−50.8%Price at 40% of the range+76.1%
Distance from the all-time high
−61.7%

Our own calculation from the exchange’s daily candles, as of Oct 27, 2026. “All-time” applies since the start of this series, not to the whole market. Changes in percent; the TradingView chart shows prices. “Today” = change of the last trading day versus the previous day. Not investment advice.

Where is the price relative to the buy zone?

No buy zone

There is currently no buy zone for this symbol under our Elliott rule. One only forms when the price pulls back after a strong rise.

An observation, not investment advice

Rule (4-hour candles) No current buy zone · as of Oct 15, 2026

Watcher Full history: every change of the buy zone with its date.

Automated analysis (rule-based)

How we analyze

Timeframe 4 hours · As of Oct 27, 2026

Elliott wave analysis Hims & Hers Health (4-hour candles): Zigzag (A-B-C), Corrective pattern (downward), C in progress (3 of 3 guidelines); no buy zone of the rule on this timeframe. Candlestick chart HIMS with 105 4-hour candles from Aug 13, 2026, 19:30 to Oct 27, 2026, 18:30. No buy zone of the rule on this timeframe – only the Elliott count: Zigzag (A-B-C), Corrective pattern (downward), C in progress (3 of 3 guidelines) (B = 66% of A; C = 71% of A), invalid on a close above the end of B. Alternative: Combination (W-X-Y), Corrective pattern (downward), Y in progress (3 of 3 guidelines). Fibonacci target zones for this count from Watcher. No value axis. Automated analysis (rule-based), not investment advice. HIMS · 4-hour candles · Automated analysis (rule-based) No buy zone of the rule – Elliott count only Fibonacci target zones for this count from Watcher invalid on a close above the end of B 0 A B C in progress (i) (ii) (iii) Aug 18 Aug 27 Sep 8 Sep 17 Sep 28 Oct 7 Oct 16 last candle Oct 27, 2026, 18:30 · not investment advice Without a buy zone of the rule: no value axis
  • 4-hour candles (green = close above open, red = below)
  • Elliott count (thin gold line, waves in circles; dashed circle = still in progress; small = subwaves; red dashed = invalidation level)
  • Watcher Fibonacci target zones for this count from Watcher

Elliott count: Zigzag (A-B-C), Corrective pattern (downward), C in progress (3 of 3 guidelines) · B = 66% of A; C = 71% of A

Alternative (not drawn): Combination (W-X-Y), Corrective pattern (downward), Y in progress (3 of 3 guidelines)

Note: Structure ambiguous: leg A can also be read as three- or five-part.

Note: Retracement at least 88.7% of A: flat possible (B in progress, type only with C).

Elliott count calculated automatically by fixed Elliott rules, not investment advice – display only, our buy zones do not use it. Provisional: The count can change with new candles.

Scenarios

Timeframe 4 hours · As of Oct 27, 2026 · from the Elliott count in the analysis chart

Weighting Main scenario and alternative: level (3 of 3 guidelines each, strong) – the simpler or clearer pattern counts as the main scenario.

Weighting by guidelines met – not a probability.

Main scenario

tied strong · 3 of 3 guidelines

As long as the 4-hour close stays below the end of B, this applies: sharp countermove downward in three waves (Zigzag A-B-C), C in progress – count points to falling prices.

Invalid if the 4-hour close is above the end of B

Alternative

tied strong · 3 of 3 guidelines

If that breaks, the second reading no longer applies either: complex countermove downward (Combination W-X-Y), Y in progress – then there is no valid count for now; the next candles will produce a new one.

Invalid if the 4-hour close is above the end of X

Watcher Fibonacci target zones and levels for this count – as a help for your own review – from Watcher.

Fundamental analysis

Hims & Hers Health · amounts in USD

Information only – does not affect our buy zones, not investment advice. Source: SEC filings, As of Feb 23, 2026.

In short

  • Light green: Revenue grew over 5 years (+73.6% per year).
  • Light green: Net margin 5.5%.
  • Light red: Profit in 2 of 7 fiscal years.

Summarized from the lights below. Describes the reported figures – not a recommendation to buy or sell.

RevenueNet income Net margin (below) in USD
  1. Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Revenue 82.6M USD · Net income −72.1M USD · Net margin −87.3%
  2. Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Revenue 148.8M USD · Net income −3.0M USD · Net margin −2.0%
  3. Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Revenue 271.9M USD · Net income −107.7M USD · Net margin −39.6%
  4. Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Revenue 526.9M USD · Net income −65.7M USD · Net margin −12.5%
  5. Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Revenue 872.0M USD · Net income −23.5M USD · Net margin −2.7%
  6. Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Revenue 1.5B USD · Net income 126.0M USD · Net margin 8.5%
  7. Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 2.3B USD · Net income 128.4M USD · Net margin 5.5%

Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 2.3B USD · Net income 128.4M USD · Net margin 5.5%

Key figures with traffic lights

Each light follows a simple, disclosed rule. This symbol has no sector assignment – lights with a sector comparison stay gray or use only the basic rule.

Revenue growth

Light green: growing

+73.6% per year, last 5 years

What does this mean? Revenue: over 5 years it grew by 73.6% per year on average. Comparable values for a sector comparison are missing.

Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.

Net income (total)

Light gray: not computable

– per year, last 5 years

per share: not computable (loss in the first or last year)

What does this mean? There was a loss in the first or last year. An annual growth rate cannot be calculated meaningfully then.

Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.

Net margin

Light green: Gain

5.5% last fiscal year

What does this mean? Of every 100 USD in revenue, 5.47 USD remained as profit. Comparable values for a sector comparison are missing.

Light rule: Green: at least the sector median (without a sector comparison: profit) · Yellow: profit, but below the median · Red: loss.

Debt / equity

Light gray: not available

– latest balance sheet

What does this mean? No usable figure: reported financial debt or positive equity for the same balance sheet date is missing.

Light rule: Green: at most the sector median · Yellow: up to twice the median · Red: more than twice · Gray: without a sector comparison.

Payout ratio

Light gray: none found

– Dividend / earnings per share

What does this mean? The loaded SEC filings of the last two fiscal years contain no dividend per share. Either the company pays none, or it reports it under a different tag.

Light rule: Green: up to 60% of earnings · Yellow: up to 100% · Red: more than earnings or a dividend despite a loss · Gray for real estate (REITs). The sector median is for comparison only.

Profitable years

Light red: 5 loss years

2 of 7 fiscal years with a profit

What does this mean? In 2 of the last 7 fiscal years the bottom line showed a profit. 5 years ended with a loss.

Light rule: Green: profit in every year · Yellow: one loss year · Red: several loss years (at least 3 years needed).

Last fiscal year and 13F

Information, not a trading signal · Source: SEC EDGAR
Revenue (FY)
2.3B USD
Revenue vs. prior year
+59.0%
Net income (FY)
128.4M USD
Net income vs. prior year
+1.8%
EPS (FY)
0.51 USD
13F funds with a position
1 of 9
Funds vs. prior quarter
+1
Shares held vs. prior quarter
–
Fiscal year to Dec 31, 2025 · 10-K filed Feb 23, 2026 · Price-based figures (P/E, P/S, dividend yield, market cap) only when logged in. · Values as first reported; debt = reported financial debt (US GAAP: long-term). 13F: reporting date Jun 30, 2026, 9 tracked funds have filed (latest Aug 14, 2026), filed with up to 45 days of delay. Stock positions only; comparison with Mar 31, 2026 only across funds that filed for both quarters.
All figures as a table
Fiscal years (amounts in USD, per share in USD)
YearEndRevenueNet income MarginEarnings per shareDividend per sharePayout
2025Dec 31, 2025 2.3B128.4M 5.5% 0.51 – –
2024Dec 31, 2024 1.5B126.0M 8.5% 0.53 – –
2023Dec 31, 2023 872.0M−23.5M −2.7% −0.11 – –
2022Dec 31, 2022 526.9M−65.7M −12.5% −0.32 – –
2021Dec 31, 2021 271.9M−107.7M −39.6% −0.58 – –
2020Dec 31, 2020 148.8M−3.0M −2.0% −0.51 – –
2019Dec 31, 2019 82.6M−72.1M −87.3% −2.07 – –
Quarters (amounts in USD, per share in USD)
QuarterEndRevenueNet income MarginEarnings per shareDividend per sharePayout
Q2/26Jun 30, 2026 753.2M−86.3M −11.5% −0.37 – –
Q1/26Mar 31, 2026 608.1M−92.1M −15.1% −0.40 – –
Q4/25*Dec 31, 2025 617.8M20.6M 3.3% – – –
Q3/25Sep 30, 2025 599.0M15.8M 2.6% 0.06 – –
Q2/25Jun 30, 2025 544.8M42.5M 7.8% 0.17 – –
Q1/25Mar 31, 2025 586.0M49.5M 8.4% 0.20 – –
Q4/24*Dec 31, 2024 481.1M26.0M 5.4% – – –
Q3/24Sep 30, 2024 401.6M75.6M 18.8% 0.32 – –
Q2/24Jun 30, 2024 315.6M13.3M 4.2% 0.06 – –
Q1/24Mar 31, 2024 278.2M11.1M 4.0% 0.05 – –
Q4/23*Dec 31, 2023 246.6M1.2M 0.5% – – –
Q3/23Sep 30, 2023 226.7M−7.6M −3.3% −0.04 – –

* Q4 derived: fiscal year minus the 9-month value (EPS cannot be derived this way); may be distorted by restatements.

How we calculate: values as first reported to the SEC (later corrections are left out), a fixed order of reporting tags per figure, partial sums are never added up. Growth per year over 5 years (otherwise 3 years). Quarters are labeled by the calendar quarter in which they end.

Insiders

All insider transactions
Insider purchases and sales on the market over 3, 6 and 12 months
PeriodPurchasesSalesNet
3 months $00 people $4.0M5 people −$4.0M
6 months $1.2M1 person $9.8M7 people −$8.6M
12 months $1.2M1 person $19.3M8 people −$18.1M

Latest transactions

  • Oct 14, 2026 Boughton Soleil Officer Open-market sale · 10b5-1 plan 3,461 shares · $100.6K · SEC
  • Oct 1, 2026 Okupe Oluyemi Chief financial officer (CFO) Open-market sale · 10b5-1 plan 2,000 shares · $59.4K · SEC
  • Sep 30, 2026 Boughton Soleil Officer Open-market sale · 10b5-1 plan 3,461 shares · $101.0K · SEC
  • Sep 22, 2026 Okupe Oluyemi Chief financial officer (CFO) Open-market sale · 10b5-1 plan 29,277 shares · $876.8K · SEC
  • Sep 17, 2026 Okupe Oluyemi Chief financial officer (CFO) Open-market sale · 10b5-1 plan 12,313 shares · $354.9K · SEC
  • Sep 16, 2026 Boughton Soleil Officer Open-market sale · 10b5-1 plan 6,236 shares · $173.7K · SEC

Source: mandatory filings with the SEC (Form 4), open-market purchases and sales only. General information, not investment advice.

Trend score -65

Price vs. EMA 50-15
Price vs. EMA 200-15
EMA 50 vs. EMA 200-20
ADX (trend strength)+0
Highs and lows+0
Relative strength-15

Volatility and trend strength

ADX 14 (trend strength)12.8
Rel. strength 60 d−10.3%

ATR and moving averages as price values only when logged in.

More stocks from Other stocks

All symbols in this sector

News

Latest news

Posts

No posts on HIMS yet – log in to join the discussion.

Posts are opinions of users and only visible after logging in. Community rules

Set alert: HIMS

Alerts with a free account: we send you an email as soon as the price moves above or below your level, reaches the buy zone or the buy zone becomes invalid.

Checked after every data update: crypto hourly (buy zones every 4 hours), stocks twice a day, precious metals every 4 hours on trading days, extended universe weekly – not in real time.

↑ ↓ select · Enter open · Esc close